Full Screening Solution News Today

Share this article Share this article SEOUL, Korea, May 23, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this years European Congress of Clinical Microbiology, the ECCMID. Seegenes Dr. Guy Willem Lee, Director of Marketing Strategy introduced the diagnostic system under the theme of "SARS-CoV-2 and Variants Full Screening Solution" using its late...